PTC Therapeutics | PTCT - Revenu Net

Prix De L'Action
68.23
Variation Quotidienne
-0.36 -0.52%
Mensuellement
2.22%
Annuel
37.75%
Q2 Prévisions
66.77




Revenu Net Changement Date
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xencor USD -6.65M 626K 2025-12